Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01834625 · ClinicalTrials.gov registry record
Prognostic Value of Aβ Imaging in NPH Prior to Shunt Placement
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 2
- Enrollment target
NCT01834625: Clinical Trial study, sponsored by Mayo Clinic.
NCT01834625 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01834625 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
In this pilot study the investigators shall prospectively in a blinded fashion evaluate with Aβ PET in patients committed to shunt surgery and then investigate the relationship of these biomarkers with outcome on gait, cognition and urinary control improvement in the short term (3 months) and long term (1 year). The imaging agent will be provided by AVID. Furthermore the study will standardize imaging studies using florbetapir F 18 PET to provide information on amyloid burden.
Interventions
- DIAGNOSTIC_TEST PET scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-04 |
| Est. Completion | 2017-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01834625
The ClinicalTrials.gov registry entry for NCT01834625 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PET scan is the first listed.
NCT01834625 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01834625 about?
NCT01834625 is a clinical study titled "Prognostic Value of Aβ Imaging in NPH Prior to Shunt Placement". In this pilot study the investigators shall prospectively in a blinded fashion evaluate with Aβ PET in patients committed to shunt surgery and then investigate the relationship of these biomarkers with outcome on gait, cognition and urinary control improvement in the short term (3 months) and long t...
What is the current status of trial NCT01834625?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2013-04. Estimated completion is 2017-10.
What interventions are being tested in trial NCT01834625?
The interventions under investigation include: PET scan (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01834625?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.